Biotechnology
3 Small Biotechs to Watch as Earnings Season Winds Down
One already is up nicely on its results, while the other two should issue reports of interest in the next few days.
I Like These 2 Smaller Name Biotech Stocks
I still believe it will be a big year for buyouts across the biotech industry.
Moderna's Small Base Could Surprise on the Upside
Prices have moved above the early January high giving us the simple definition of an uptrend.
It's a Stock Picker's Delight Right Now
With cash levels high, those players who are not well-positioned for upside action are scrambling to put money to work and are helping to propel prices higher.
2 Small-Cap Stocks That Are Still a Bargain
Despite the January rally, this biotech name and building materials firm still have further to rise.
2 Small-Cap Biotech Stocks That Are on My Radar
These high risk/high reward oncology names look significantly undervalued, right now.
NeoGenomics Is Poised For Further Gains - Go Long on a Shallow Dip
Let's check out the charts and indicators for a strategy that looks to balance risk and reward.
Allergan Could Retest Its December Low Before a Better Rally Attempt
Allergan could move higher but some sort of retest of the December low seems in order in the short to intermediate term.
The New Small Biotechs Heating Up the Medical Cannabis Space
These companies are working to plant their flag in a new landscape.
These 2 Biotech Stocks Seem Significantly Undervalued
I would add to them on any significant dips in the market.